Chlormadinone acetate in progestin‐primed ovarian stimulation does not negatively affect clinical results

PURPOSE: To investigate whether progestin‐primed ovarian stimulation (PPOS) with chlormadinone acetate (CMA) adversely affects clinical results and neonatal outcomes, or causes congenital deformities. METHODS: This retrospective study was conducted at private IVF clinic from November 2018 to Novembe...

Descripción completa

Detalles Bibliográficos
Autores principales: Shibasaki, Sena, Hattori, Hiromitsu, Koizumi, Masae, Nagaura, Satoko, Toya, Mayumi, Igarashi, Hideki, Kyono, Koichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10231652/
https://www.ncbi.nlm.nih.gov/pubmed/37265782
http://dx.doi.org/10.1002/rmb2.12519

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10231652/
https://www.ncbi.nlm.nih.gov/pubmed/37265782
http://dx.doi.org/10.1002/rmb2.12519

Ejemplares similares